HER2-positive metastatic breast cancer: a changing scenario.
Crit Rev Oncol Hematol
; 95(1): 78-87, 2015 Jul.
Article
in En
| MEDLINE
| ID: mdl-25748080
Full text:
1
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Receptor, ErbB-2
Type of study:
Observational_studies
Limits:
Female
/
Humans
Language:
En
Year:
2015
Type:
Article